These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 15572377)
1. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. Hendriks BS; Orr G; Wells A; Wiley HS; Lauffenburger DA J Biol Chem; 2005 Feb; 280(7):6157-69. PubMed ID: 15572377 [TBL] [Abstract][Full Text] [Related]
2. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion. Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis: distribution of homo- and heterodimers depends on relative HER2 levels. Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D J Biol Chem; 2003 Jun; 278(26):23343-51. PubMed ID: 12686539 [TBL] [Abstract][Full Text] [Related]
4. HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells. Zhang Y; Opresko L; Shankaran H; Chrisler WB; Wiley HS; Resat H BMC Cell Biol; 2009 Oct; 10():78. PubMed ID: 19878579 [TBL] [Abstract][Full Text] [Related]
5. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Li X; Huang Y; Jiang J; Frank SJ Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250 [TBL] [Abstract][Full Text] [Related]
6. Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3. Shankaran H; Zhang Y; Tan Y; Resat H PLoS Comput Biol; 2013; 9(8):e1003201. PubMed ID: 23990774 [TBL] [Abstract][Full Text] [Related]
7. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D Cancer Res; 2003 Mar; 63(5):1130-7. PubMed ID: 12615732 [TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells. Ruschel A; Ullrich A Cell Signal; 2004 Nov; 16(11):1249-61. PubMed ID: 15337524 [TBL] [Abstract][Full Text] [Related]
9. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
10. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance. Zhou H; Kim YS; Peletier A; McCall W; Earp HS; Sartor CI Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):344-52. PubMed ID: 14751502 [TBL] [Abstract][Full Text] [Related]
11. External and internal EGFR-activating signals drive mammary epithelial cells proliferation and viability. Morato A; Martignani E; Miretti S; Baratta M; Accornero P Mol Cell Endocrinol; 2021 Jan; 520():111081. PubMed ID: 33181234 [TBL] [Abstract][Full Text] [Related]
12. MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701. Chen CH; Hsia TC; Yeh MH; Chen TW; Chen YJ; Chen JT; Wei YL; Tu CY; Huang WC Mol Oncol; 2017 Sep; 11(9):1273-1287. PubMed ID: 28632938 [TBL] [Abstract][Full Text] [Related]
13. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses. Spivak-Kroizman T; Rotin D; Pinchasi D; Ullrich A; Schlessinger J; Lax I J Biol Chem; 1992 Apr; 267(12):8056-63. PubMed ID: 1349015 [TBL] [Abstract][Full Text] [Related]
14. Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation. Patel D; Bassi R; Hooper A; Prewett M; Hicklin DJ; Kang X Int J Oncol; 2009 Jan; 34(1):25-32. PubMed ID: 19082474 [TBL] [Abstract][Full Text] [Related]
15. Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking. Shankaran H; Zhang Y; Opresko L; Resat H Biochem Biophys Res Commun; 2008 Jun; 371(2):220-4. PubMed ID: 18424261 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics. Kiyatkin A; van Alderwerelt van Rosenburgh IK; Klein DE; Lemmon MA Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817373 [TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656 [TBL] [Abstract][Full Text] [Related]
18. ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. Worthylake R; Opresko LK; Wiley HS J Biol Chem; 1999 Mar; 274(13):8865-74. PubMed ID: 10085130 [TBL] [Abstract][Full Text] [Related]
19. Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients. Wang J; Hollingshead J; El-Masry N; Horncastle D; Talbot I; Tomlinson I; Alison MR; El-Bahrawy M J Gastrointest Cancer; 2012 Sep; 43(3):444-55. PubMed ID: 21989899 [TBL] [Abstract][Full Text] [Related]